The blood platelet and plasma market is expected to show significant growth during the forecast period due to rising number of patients requiring plasma and platelet transfusion throughout the world, as platelets rich plasma blood is ensured to quick healing of injuries in bones and soft tissues, which are caused during sports, accidents, and others, as it uses the plasma concentrated out one’s own blood. The growing use of platelet-rich plasma in various therapeutic areas like during the facelift, hair growth, sports, and orthopedic surgeries will also augment the growth of the market. However, the high cost of plasma therapy and the threats or consequences associated with platelet-rich plasma might restrict the growth of the market during the given time frame.
The rise in the number of cosmetic surgeries.
Increased numbers of accidents in general.
This method is still underdeveloped and its effectiveness is still under observation.
The major players profiled in the platelets rich plasma market include DePuy Synthes, Regen Lab USA LLC, Harvest Technologies, Eclipse, Regenexx, Arthrex, Inc., Grifols International S.A., Bio Product Laboratory Ltd (BPL), Biolife Plasma Services, and Kedrion S.P.A.
The Platelet Rich Plasma market has been analyzed through the following segments:
Pure Platelet-Rich Plasma (P-PRP) or Leukocyte-Poor Platelet-Rich Plasma
Leukocyte-and Platelet-Rich Plasma (L-PRP)
Pure Platelet-Rich Fibrin (P-PRF)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Middle East and Africa
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. PLATELETS RICH PLASMA MARKET BY TYPE
5.1. Pure Platelet-Rich Plasma (P-PRP) or Leukocyte-Poor Platelet-Rich Plasma
5.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
5.3. Pure Platelet-Rich Fibrin (P-PRF)
5.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
6. PLATELETS RICH PLASMA MARKET BY SOURCE
7. PLATELETS RICH PLASMA MARKET BY APPLICATION
7.1. Orthopedic Surgery
7.3. General Surgery
8. PLATELETS RICH PLASMA MARKET BY END USER
8.1. Hospitals and Clinics
8.2. Research Institutes
8.3. Ambulatory Surgical Centers
9. PLATELETS RICH PLASMA MARKET BY GEOGRAPHY
9.1. North America
9.2. South America
9.3.3. United Kingdom
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.5. Asia Pacific
9.5.3. South Korea
10. COMPETITIVE INTELLIGENCE
10.1. Competitive Benchmarking and Analysis
10.2. Recent Investments and Deals
10.3. Strategies of Key Players
11. COMPANY PROFILES
11.1. DePuy Synthes
11.2. Regen Lab USA LLC
11.3. Harvest Technologies
11.6. Arthrex Inc
11.7. Grifols International S.A.
11.8. Bio Product Laboratory Ltd (BPL)
11.9. Biolife Plasma Services
11.10. Kedrion S.P.A
The research study is based on the publisher's proprietary research model. The process involves sourcing of information from various industry experts, key professionals, decision-makers and various other stakeholders along with the validation of the responses received from the vast in-house database and premium paid databases. Publicly available sources were also taken into consideration for the final market estimates and forecast for the segments and sub-segments.
The first phase of the research process is the identification of key industry leaders, experts, decision-makers and C-level executives and then conducting interviews and surveys to gain vital insights about the market. Simultaneously, extensive secondary research is done, and key secondary data is collected as part of this process. This secondary data is collected from various databases, industry journals, whitepapers, company annual reports, research publications, and other paid data sources and relevant literature. Company profiles which include strategies, new product developments, recent investments, major products and services, financials and business plans are sourced from the annual reports, SEC filings, industry associations to preserve the quality of the information being displayed. The findings from both the primary and the secondary research process combined go under further processing for market breakdown and forecasting.
The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in a faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the collected data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting. The publisher has developed their market forecasting methodology that, in addition to the main market values, also takes into account other macroeconomic factors (global or local) that might have some bearing on the market under study. Taking all the necessary data, a robust forecast is developed using an algorithm that involves both static (multivariate) as well as dynamic (time-series) regression analysis. Special care is taken to make sure their algorithm passes the necessary statistical tests, and the mean prediction for future years obtained is reliable with a very high confidence level. Following data validation, the analysts begin to write the report presenting insights with the help of charts, graphs, and tables.